Carregant...
Left ventricular dysfunction in an idiopathic pulmonary fibrosis patient on nintedanib
Nintedanib, a tyrosine kinase inhibitor, is approved for the treatment of idiopathic pulmonary fibrosis. We report a case of left ventricular dysfunction in a patient with idiopathic pulmonary fibrosis treated with nintedanib, which recovered after cessation of nintedanib. Nintedanib may induce left...
Guardat en:
| Publicat a: | Respirol Case Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7017142/ https://ncbi.nlm.nih.gov/pubmed/32082576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.533 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|